Ban-for-Sale Process Architecture & Compliance Framework
Led the end-to-end design of Tata 1mg's ban-for-sale compliance framework, covering identification, implementation, and monitoring of banned drugs and medicines.
The framework operates at three levels: drug-level bans, product-level bans, and rules-based bans.
Collaborated with the catalog, legal, warehouse, compliance, and fulfillment centre teams to operationalise the ban process.
Supported EY compliance audits with ban screening, validation, and documentation.
The Challenge
- Ban notifications from CDSCO arrive in varied formats and require rapid interpretation and implementation.
- Rule-based bans cannot be implemented at individual product level at scale — requiring a rules engine approach.
- Establishing communication and implementation protocols across hundreds of fulfillment centres and retail stores nationally.
The Approach & Solution
- Designed the three-tier ban architecture: drug-level, product-level, and rules-based.
- Built a ban repository mapping 518+ CDSCO notifications to Tata 1mg's internal database.
- Automated the OTC SKU ban scoring and notification mapping process in collaboration with the Business Intelligence team.
- Established ban SOPs, communication templates, and a review pipeline.
- Worked with the EY audit team on ban screening and validation for 108 salts, all confirmed compliant.
Key Results & Commercial Impact
Technology Stack & Tools
Have a similar project in mind?
We specialize in custom AI systems, clinical data licensing pipelines, and scalable web apps. Let's build something exceptional together.
Explore More Projects
Google Health Partnership
Packaged clinical content as LLM training data, including drug monographs, DDI data, disease content, and regulatory safety data, in a B2B monetization deal.
Samsung Health API Integration
Real-time API integration spanning 600K+ SKUs, 50+ attributes, and a 200K-interaction DDI tool, enabling in-app discovery and routing cart/checkout to Tata 1mg.
Elsevier Clinical Monograph API Partnership
Tata 1mg's first clinical content licensing deal. Delivered 1,500 structured drug monographs over 9 months and built the CMS & API infrastructure.